世界の院内感染症治療市場規模・現状・予測2021-2027

【英語タイトル】Global Hospital Acquired Infection Treatment Market Size, Status and Forecast 2021-2027

QYResearchが出版した調査資料(QY21APR2904)・商品コード:QY21APR2904
・発行会社(調査会社):QYResearch
・発行日:2021年4月(※2024年版があります。お問い合わせください)
・ページ数:130
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査資料では、院内感染症治療の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(尿路感染症、換気装置関連肺炎、手術部位感染症、血流感染症、胃腸感染症、ENT感染症、皮膚感染症、骨感染症)、用途別市場規模(病院薬局、小売薬局、ドラッグストア、Eコマース)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・院内感染症治療の市場動向
・企業の競争状況、市場シェア
・院内感染症治療の種類別市場規模(尿路感染症、換気装置関連肺炎、手術部位感染症、血流感染症、胃腸感染症、ENT感染症、皮膚感染症、骨感染症)
・院内感染症治療の用途別市場規模(病院薬局、小売薬局、ドラッグストア、Eコマース)
・院内感染症治療の北米市場規模2016-2027(アメリカ、カナダ)
・院内感染症治療の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・院内感染症治療のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・院内感染症治療の中南米市場規模2016-2027(メキシコ、ブラジル)
・院内感染症治療の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Abbott、Pfizer、Bayer、Cepheid、AstraZeneca、Roche、Johnson & Johnson、Merck、Cipla、GlaxoSmithKline、Aridis Pharmaceuticals、Astellas Pharma、Daiichi Sankyo、Bristol-Myers Squibb、Eli Lilly)
・結論
【レポートの概要】

Hospital Acquired Infection Treatment is an infection that is acquired in a hospital or other health care facility.

Market Analysis and Insights: Global Hospital Acquired Infection Treatment Market
The global Hospital Acquired Infection Treatment market size is projected to reach US$ 21430 million by 2026, from US$ 19090 million in 2019, at a CAGR of 1.6% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Hospital Acquired Infection Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Hospital Acquired Infection Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Hospital Acquired Infection Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Hospital Acquired Infection Treatment market.

Global Hospital Acquired Infection Treatment Scope and Market Size
Hospital Acquired Infection Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Hospital Acquired Infection Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Urinary Tract Infections
Ventilator Associated Pneumonia
Surgical Site Infections
Bloodstream Infections
Gastrointestinal Infection
ENT Infections
Skin Infection
Bone Infection

Segment by Application
Hospital Pharmacies
Retail Pharmacies
Drug Store
E-Commerce

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Abbott
Pfizer
Bayer
Cepheid
AstraZeneca
Roche
Johnson & Johnson
Merck
Cipla
Cepheid
AstraZeneca
Astellas Pharma
Daiichi Sankyo

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hospital Acquired Infection Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Urinary Tract Infections
1.2.3 Ventilator Associated Pneumonia
1.2.4 Surgical Site Infections
1.2.5 Bloodstream Infections
1.2.6 Gastrointestinal Infection
1.2.7 ENT Infections
1.2.8 Skin Infection
1.2.9 Bone Infection
1.3 Market by Application
1.3.1 Global Hospital Acquired Infection Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Drug Store
1.3.5 E-Commerce
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Hospital Acquired Infection Treatment Market Perspective (2016-2027)
2.2 Hospital Acquired Infection Treatment Growth Trends by Regions
2.2.1 Hospital Acquired Infection Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Hospital Acquired Infection Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Hospital Acquired Infection Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Hospital Acquired Infection Treatment Industry Dynamic
2.3.1 Hospital Acquired Infection Treatment Market Trends
2.3.2 Hospital Acquired Infection Treatment Market Drivers
2.3.3 Hospital Acquired Infection Treatment Market Challenges
2.3.4 Hospital Acquired Infection Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Hospital Acquired Infection Treatment Players by Revenue
3.1.1 Global Top Hospital Acquired Infection Treatment Players by Revenue (2016-2021)
3.1.2 Global Hospital Acquired Infection Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Hospital Acquired Infection Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Hospital Acquired Infection Treatment Revenue
3.4 Global Hospital Acquired Infection Treatment Market Concentration Ratio
3.4.1 Global Hospital Acquired Infection Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hospital Acquired Infection Treatment Revenue in 2020
3.5 Hospital Acquired Infection Treatment Key Players Head office and Area Served
3.6 Key Players Hospital Acquired Infection Treatment Product Solution and Service
3.7 Date of Enter into Hospital Acquired Infection Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Hospital Acquired Infection Treatment Breakdown Data by Type
4.1 Global Hospital Acquired Infection Treatment Historic Market Size by Type (2016-2021)
4.2 Global Hospital Acquired Infection Treatment Forecasted Market Size by Type (2022-2027)

5 Hospital Acquired Infection Treatment Breakdown Data by Application
5.1 Global Hospital Acquired Infection Treatment Historic Market Size by Application (2016-2021)
5.2 Global Hospital Acquired Infection Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Hospital Acquired Infection Treatment Market Size (2016-2027)
6.2 North America Hospital Acquired Infection Treatment Market Size by Type
6.2.1 North America Hospital Acquired Infection Treatment Market Size by Type (2016-2021)
6.2.2 North America Hospital Acquired Infection Treatment Market Size by Type (2022-2027)
6.2.3 North America Hospital Acquired Infection Treatment Market Size by Type (2016-2027)
6.3 North America Hospital Acquired Infection Treatment Market Size by Application
6.3.1 North America Hospital Acquired Infection Treatment Market Size by Application (2016-2021)
6.3.2 North America Hospital Acquired Infection Treatment Market Size by Application (2022-2027)
6.3.3 North America Hospital Acquired Infection Treatment Market Size by Application (2016-2027)
6.4 North America Hospital Acquired Infection Treatment Market Size by Country
6.4.1 North America Hospital Acquired Infection Treatment Market Size by Country (2016-2021)
6.4.2 North America Hospital Acquired Infection Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Hospital Acquired Infection Treatment Market Size (2016-2027)
7.2 Europe Hospital Acquired Infection Treatment Market Size by Type
7.2.1 Europe Hospital Acquired Infection Treatment Market Size by Type (2016-2021)
7.2.2 Europe Hospital Acquired Infection Treatment Market Size by Type (2022-2027)
7.2.3 Europe Hospital Acquired Infection Treatment Market Size by Type (2016-2027)
7.3 Europe Hospital Acquired Infection Treatment Market Size by Application
7.3.1 Europe Hospital Acquired Infection Treatment Market Size by Application (2016-2021)
7.3.2 Europe Hospital Acquired Infection Treatment Market Size by Application (2022-2027)
7.3.3 Europe Hospital Acquired Infection Treatment Market Size by Application (2016-2027)
7.4 Europe Hospital Acquired Infection Treatment Market Size by Country
7.4.1 Europe Hospital Acquired Infection Treatment Market Size by Country (2016-2021)
7.4.2 Europe Hospital Acquired Infection Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Hospital Acquired Infection Treatment Market Size (2016-2027)
8.2 Asia-Pacific Hospital Acquired Infection Treatment Market Size by Type
8.2.1 Asia-Pacific Hospital Acquired Infection Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Hospital Acquired Infection Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Hospital Acquired Infection Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Hospital Acquired Infection Treatment Market Size by Application
8.3.1 Asia-Pacific Hospital Acquired Infection Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Hospital Acquired Infection Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Hospital Acquired Infection Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Hospital Acquired Infection Treatment Market Size by Region
8.4.1 Asia-Pacific Hospital Acquired Infection Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Hospital Acquired Infection Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Hospital Acquired Infection Treatment Market Size (2016-2027)
9.2 Latin America Hospital Acquired Infection Treatment Market Size by Type
9.2.1 Latin America Hospital Acquired Infection Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Hospital Acquired Infection Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Hospital Acquired Infection Treatment Market Size by Type (2016-2027)
9.3 Latin America Hospital Acquired Infection Treatment Market Size by Application
9.3.1 Latin America Hospital Acquired Infection Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Hospital Acquired Infection Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Hospital Acquired Infection Treatment Market Size by Application (2016-2027)
9.4 Latin America Hospital Acquired Infection Treatment Market Size by Country
9.4.1 Latin America Hospital Acquired Infection Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Hospital Acquired Infection Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Hospital Acquired Infection Treatment Market Size (2016-2027)
10.2 Middle East & Africa Hospital Acquired Infection Treatment Market Size by Type
10.2.1 Middle East & Africa Hospital Acquired Infection Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Hospital Acquired Infection Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Hospital Acquired Infection Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Hospital Acquired Infection Treatment Market Size by Application
10.3.1 Middle East & Africa Hospital Acquired Infection Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Hospital Acquired Infection Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Hospital Acquired Infection Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Hospital Acquired Infection Treatment Market Size by Country
10.4.1 Middle East & Africa Hospital Acquired Infection Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Hospital Acquired Infection Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Hospital Acquired Infection Treatment Introduction
11.1.4 Abbott Revenue in Hospital Acquired Infection Treatment Business (2016-2021)
11.1.5 Abbott Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Hospital Acquired Infection Treatment Introduction
11.2.4 Pfizer Revenue in Hospital Acquired Infection Treatment Business (2016-2021)
11.2.5 Pfizer Recent Development
11.3 Bayer
11.3.1 Bayer Company Details
11.3.2 Bayer Business Overview
11.3.3 Bayer Hospital Acquired Infection Treatment Introduction
11.3.4 Bayer Revenue in Hospital Acquired Infection Treatment Business (2016-2021)
11.3.5 Bayer Recent Development
11.4 Cepheid
11.4.1 Cepheid Company Details
11.4.2 Cepheid Business Overview
11.4.3 Cepheid Hospital Acquired Infection Treatment Introduction
11.4.4 Cepheid Revenue in Hospital Acquired Infection Treatment Business (2016-2021)
11.4.5 Cepheid Recent Development
11.5 AstraZeneca
11.5.1 AstraZeneca Company Details
11.5.2 AstraZeneca Business Overview
11.5.3 AstraZeneca Hospital Acquired Infection Treatment Introduction
11.5.4 AstraZeneca Revenue in Hospital Acquired Infection Treatment Business (2016-2021)
11.5.5 AstraZeneca Recent Development
11.6 Roche
11.6.1 Roche Company Details
11.6.2 Roche Business Overview
11.6.3 Roche Hospital Acquired Infection Treatment Introduction
11.6.4 Roche Revenue in Hospital Acquired Infection Treatment Business (2016-2021)
11.6.5 Roche Recent Development
11.7 Johnson & Johnson
11.7.1 Johnson & Johnson Company Details
11.7.2 Johnson & Johnson Business Overview
11.7.3 Johnson & Johnson Hospital Acquired Infection Treatment Introduction
11.7.4 Johnson & Johnson Revenue in Hospital Acquired Infection Treatment Business (2016-2021)
11.7.5 Johnson & Johnson Recent Development
11.8 Merck
11.8.1 Merck Company Details
11.8.2 Merck Business Overview
11.8.3 Merck Hospital Acquired Infection Treatment Introduction
11.8.4 Merck Revenue in Hospital Acquired Infection Treatment Business (2016-2021)
11.8.5 Merck Recent Development
11.9 Cipla
11.9.1 Cipla Company Details
11.9.2 Cipla Business Overview
11.9.3 Cipla Hospital Acquired Infection Treatment Introduction
11.9.4 Cipla Revenue in Hospital Acquired Infection Treatment Business (2016-2021)
11.9.5 Cipla Recent Development
11.10 GlaxoSmithKline
11.10.1 GlaxoSmithKline Company Details
11.10.2 GlaxoSmithKline Business Overview
11.10.3 GlaxoSmithKline Hospital Acquired Infection Treatment Introduction
11.10.4 GlaxoSmithKline Revenue in Hospital Acquired Infection Treatment Business (2016-2021)
11.10.5 GlaxoSmithKline Recent Development
11.11 Aridis Pharmaceuticals
11.11.1 Aridis Pharmaceuticals Company Details
11.11.2 Aridis Pharmaceuticals Business Overview
11.11.3 Aridis Pharmaceuticals Hospital Acquired Infection Treatment Introduction
11.11.4 Aridis Pharmaceuticals Revenue in Hospital Acquired Infection Treatment Business (2016-2021)
11.11.5 Aridis Pharmaceuticals Recent Development
11.12 Astellas Pharma
11.12.1 Astellas Pharma Company Details
11.12.2 Astellas Pharma Business Overview
11.12.3 Astellas Pharma Hospital Acquired Infection Treatment Introduction
11.12.4 Astellas Pharma Revenue in Hospital Acquired Infection Treatment Business (2016-2021)
11.12.5 Astellas Pharma Recent Development
11.13 Daiichi Sankyo
11.13.1 Daiichi Sankyo Company Details
11.13.2 Daiichi Sankyo Business Overview
11.13.3 Daiichi Sankyo Hospital Acquired Infection Treatment Introduction
11.13.4 Daiichi Sankyo Revenue in Hospital Acquired Infection Treatment Business (2016-2021)
11.13.5 Daiichi Sankyo Recent Development
11.14 Bristol-Myers Squibb
11.14.1 Bristol-Myers Squibb Company Details
11.14.2 Bristol-Myers Squibb Business Overview
11.14.3 Bristol-Myers Squibb Hospital Acquired Infection Treatment Introduction
11.14.4 Bristol-Myers Squibb Revenue in Hospital Acquired Infection Treatment Business (2016-2021)
11.14.5 Bristol-Myers Squibb Recent Development
11.15 Eli Lilly
11.15.1 Eli Lilly Company Details
11.15.2 Eli Lilly Business Overview
11.15.3 Eli Lilly Hospital Acquired Infection Treatment Introduction
11.15.4 Eli Lilly Revenue in Hospital Acquired Infection Treatment Business (2016-2021)
11.15.5 Eli Lilly Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Hospital Acquired Infection Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Urinary Tract Infections
Table 3. Key Players of Ventilator Associated Pneumonia
Table 4. Key Players of Surgical Site Infections
Table 5. Key Players of Bloodstream Infections
Table 6. Key Players of Gastrointestinal Infection
Table 7. Key Players of ENT Infections
Table 8. Key Players of Skin Infection
Table 9. Key Players of Bone Infection
Table 10. Global Hospital Acquired Infection Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 11. Global Hospital Acquired Infection Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 12. Global Hospital Acquired Infection Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 13. Global Hospital Acquired Infection Treatment Market Share by Regions (2016-2021)
Table 14. Global Hospital Acquired Infection Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 15. Global Hospital Acquired Infection Treatment Market Share by Regions (2022-2027)
Table 16. Hospital Acquired Infection Treatment Market Trends
Table 17. Hospital Acquired Infection Treatment Market Drivers
Table 18. Hospital Acquired Infection Treatment Market Challenges
Table 19. Hospital Acquired Infection Treatment Market Restraints
Table 20. Global Hospital Acquired Infection Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 21. Global Hospital Acquired Infection Treatment Market Share by Players (2016-2021)
Table 22. Global Top Hospital Acquired Infection Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hospital Acquired Infection Treatment as of 2020)
Table 23. Ranking of Global Top Hospital Acquired Infection Treatment Companies by Revenue (US$ Million) in 2020
Table 24. Global 5 Largest Players Market Share by Hospital Acquired Infection Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Hospital Acquired Infection Treatment Product Solution and Service
Table 27. Date of Enter into Hospital Acquired Infection Treatment Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Hospital Acquired Infection Treatment Market Size by Type (2016-2021) (US$ Million)
Table 30. Global Hospital Acquired Infection Treatment Revenue Market Share by Type (2016-2021)
Table 31. Global Hospital Acquired Infection Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 32. Global Hospital Acquired Infection Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 33. Global Hospital Acquired Infection Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 34. Global Hospital Acquired Infection Treatment Revenue Market Share by Application (2016-2021)
Table 35. Global Hospital Acquired Infection Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 36. Global Hospital Acquired Infection Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 37. North America Hospital Acquired Infection Treatment Market Size by Type (2016-2021) (US$ Million)
Table 38. North America Hospital Acquired Infection Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 39. North America Hospital Acquired Infection Treatment Market Size by Application (2016-2021) (US$ Million)
Table 40. North America Hospital Acquired Infection Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 41. North America Hospital Acquired Infection Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 42. North America Hospital Acquired Infection Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 43. Europe Hospital Acquired Infection Treatment Market Size by Type (2016-2021) (US$ Million)
Table 44. Europe Hospital Acquired Infection Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 45. Europe Hospital Acquired Infection Treatment Market Size by Application (2016-2021) (US$ Million)
Table 46. Europe Hospital Acquired Infection Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 47. Europe Hospital Acquired Infection Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 48. Europe Hospital Acquired Infection Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Hospital Acquired Infection Treatment Market Size by Type (2016-2021) (US$ Million)
Table 50. Asia-Pacific Hospital Acquired Infection Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Hospital Acquired Infection Treatment Market Size by Application (2016-2021) (US$ Million)
Table 52. Asia-Pacific Hospital Acquired Infection Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 53. Asia-Pacific Hospital Acquired Infection Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 54. Asia-Pacific Hospital Acquired Infection Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 55. Latin America Hospital Acquired Infection Treatment Market Size by Type (2016-2021) (US$ Million)
Table 56. Latin America Hospital Acquired Infection Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 57. Latin America Hospital Acquired Infection Treatment Market Size by Application (2016-2021) (US$ Million)
Table 58. Latin America Hospital Acquired Infection Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 59. Latin America Hospital Acquired Infection Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 60. Latin America Hospital Acquired Infection Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Hospital Acquired Infection Treatment Market Size by Type (2016-2021) (US$ Million)
Table 62. Middle East & Africa Hospital Acquired Infection Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Hospital Acquired Infection Treatment Market Size by Application (2016-2021) (US$ Million)
Table 64. Middle East & Africa Hospital Acquired Infection Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 65. Middle East & Africa Hospital Acquired Infection Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 66. Middle East & Africa Hospital Acquired Infection Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 67. Abbott Company Details
Table 68. Abbott Business Overview
Table 69. Abbott Hospital Acquired Infection Treatment Product
Table 70. Abbott Revenue in Hospital Acquired Infection Treatment Business (2016-2021) & (US$ Million)
Table 71. Abbott Recent Development
Table 72. Pfizer Company Details
Table 73. Pfizer Business Overview
Table 74. Pfizer Hospital Acquired Infection Treatment Product
Table 75. Pfizer Revenue in Hospital Acquired Infection Treatment Business (2016-2021) & (US$ Million)
Table 76. Pfizer Recent Development
Table 77. Bayer Company Details
Table 78. Bayer Business Overview
Table 79. Bayer Hospital Acquired Infection Treatment Product
Table 80. Bayer Revenue in Hospital Acquired Infection Treatment Business (2016-2021) & (US$ Million)
Table 81. Bayer Recent Development
Table 82. Cepheid Company Details
Table 83. Cepheid Business Overview
Table 84. Cepheid Hospital Acquired Infection Treatment Product
Table 85. Cepheid Revenue in Hospital Acquired Infection Treatment Business (2016-2021) & (US$ Million)
Table 86. Cepheid Recent Development
Table 87. AstraZeneca Company Details
Table 88. AstraZeneca Business Overview
Table 89. AstraZeneca Hospital Acquired Infection Treatment Product
Table 90. AstraZeneca Revenue in Hospital Acquired Infection Treatment Business (2016-2021) & (US$ Million)
Table 91. AstraZeneca Recent Development
Table 92. Roche Company Details
Table 93. Roche Business Overview
Table 94. Roche Hospital Acquired Infection Treatment Product
Table 95. Roche Revenue in Hospital Acquired Infection Treatment Business (2016-2021) & (US$ Million)
Table 96. Roche Recent Development
Table 97. Johnson & Johnson Company Details
Table 98. Johnson & Johnson Business Overview
Table 99. Johnson & Johnson Hospital Acquired Infection Treatment Product
Table 100. Johnson & Johnson Revenue in Hospital Acquired Infection Treatment Business (2016-2021) & (US$ Million)
Table 101. Johnson & Johnson Recent Development
Table 102. Merck Company Details
Table 103. Merck Business Overview
Table 104. Merck Revenue in Hospital Acquired Infection Treatment Business (2016-2021) & (US$ Million)
Table 105. Merck Recent Development
Table 106. Cipla Company Details
Table 107. Cipla Business Overview
Table 108. Cipla Hospital Acquired Infection Treatment Product
Table 109. Cipla Revenue in Hospital Acquired Infection Treatment Business (2016-2021) & (US$ Million)
Table 110. Cipla Recent Development
Table 111. GlaxoSmithKline Company Details
Table 112. GlaxoSmithKline Business Overview
Table 113. GlaxoSmithKline Hospital Acquired Infection Treatment Product
Table 114. GlaxoSmithKline Revenue in Hospital Acquired Infection Treatment Business (2016-2021) & (US$ Million)
Table 115. GlaxoSmithKline Recent Development
Table 116. Aridis Pharmaceuticals Company Details
Table 117. Aridis Pharmaceuticals Business Overview
Table 118. Aridis Pharmaceuticals Hospital Acquired Infection Treatment Product
Table 119. Aridis Pharmaceuticals Revenue in Hospital Acquired Infection Treatment Business (2016-2021) & (US$ Million)
Table 120. Aridis Pharmaceuticals Recent Development
Table 121. Astellas Pharma Company Details
Table 122. Astellas Pharma Business Overview
Table 123. Astellas Pharma Hospital Acquired Infection Treatment Product
Table 124. Astellas Pharma Revenue in Hospital Acquired Infection Treatment Business (2016-2021) & (US$ Million)
Table 125. Astellas Pharma Recent Development
Table 126. Daiichi Sankyo Company Details
Table 127. Daiichi Sankyo Business Overview
Table 128. Daiichi Sankyo Hospital Acquired Infection Treatment Product
Table 129. Daiichi Sankyo Revenue in Hospital Acquired Infection Treatment Business (2016-2021) & (US$ Million)
Table 130. Daiichi Sankyo Recent Development
Table 131. Bristol-Myers Squibb Company Details
Table 132. Bristol-Myers Squibb Business Overview
Table 133. Bristol-Myers Squibb Hospital Acquired Infection Treatment Product
Table 134. Bristol-Myers Squibb Revenue in Hospital Acquired Infection Treatment Business (2016-2021) & (US$ Million)
Table 135. Bristol-Myers Squibb Recent Development
Table 136. Eli Lilly Company Details
Table 137. Eli Lilly Business Overview
Table 138. Eli Lilly Hospital Acquired Infection Treatment Product
Table 139. Eli Lilly Revenue in Hospital Acquired Infection Treatment Business (2016-2021) & (US$ Million)
Table 140. Eli Lilly Recent Development
Table 141. Research Programs/Design for This Report
Table 142. Key Data Information from Secondary Sources
Table 143. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hospital Acquired Infection Treatment Market Share by Type: 2020 VS 2027
Figure 2. Urinary Tract Infections Features
Figure 3. Ventilator Associated Pneumonia Features
Figure 4. Surgical Site Infections Features
Figure 5. Bloodstream Infections Features
Figure 6. Gastrointestinal Infection Features
Figure 7. ENT Infections Features
Figure 8. Skin Infection Features
Figure 9. Bone Infection Features
Figure 10. Global Hospital Acquired Infection Treatment Market Share by Application: 2020 VS 2027
Figure 11. Hospital Pharmacies Case Studies
Figure 12. Retail Pharmacies Case Studies
Figure 13. Drug Store Case Studies
Figure 14. E-Commerce Case Studies
Figure 15. Hospital Acquired Infection Treatment Report Years Considered
Figure 16. Global Hospital Acquired Infection Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 17. Global Hospital Acquired Infection Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 18. Global Hospital Acquired Infection Treatment Market Share by Regions: 2020 VS 2027
Figure 19. Global Hospital Acquired Infection Treatment Market Share by Regions (2022-2027)
Figure 20. Global Hospital Acquired Infection Treatment Market Share by Players in 2020
Figure 21. Global Top Hospital Acquired Infection Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hospital Acquired Infection Treatment as of 2020
Figure 22. The Top 10 and 5 Players Market Share by Hospital Acquired Infection Treatment Revenue in 2020
Figure 23. Global Hospital Acquired Infection Treatment Revenue Market Share by Type (2016-2021)
Figure 24. Global Hospital Acquired Infection Treatment Revenue Market Share by Type (2022-2027)
Figure 25. North America Hospital Acquired Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. North America Hospital Acquired Infection Treatment Market Share by Type (2016-2027)
Figure 27. North America Hospital Acquired Infection Treatment Market Share by Application (2016-2027)
Figure 28. North America Hospital Acquired Infection Treatment Market Share by Country (2016-2027)
Figure 29. United States Hospital Acquired Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Canada Hospital Acquired Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Europe Hospital Acquired Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Europe Hospital Acquired Infection Treatment Market Share by Type (2016-2027)
Figure 33. Europe Hospital Acquired Infection Treatment Market Share by Application (2016-2027)
Figure 34. Europe Hospital Acquired Infection Treatment Market Share by Country (2016-2027)
Figure 35. Germany Hospital Acquired Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. France Hospital Acquired Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. U.K. Hospital Acquired Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Italy Hospital Acquired Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Russia Hospital Acquired Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Nordic Hospital Acquired Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Asia-Pacific Hospital Acquired Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Asia-Pacific Hospital Acquired Infection Treatment Market Share by Type (2016-2027)
Figure 43. Asia-Pacific Hospital Acquired Infection Treatment Market Share by Application (2016-2027)
Figure 44. Asia-Pacific Hospital Acquired Infection Treatment Market Share by Region (2016-2027)
Figure 45. China Hospital Acquired Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Japan Hospital Acquired Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. South Korea Hospital Acquired Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Southeast Asia Hospital Acquired Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. India Hospital Acquired Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Australia Hospital Acquired Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Latin America Hospital Acquired Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Latin America Hospital Acquired Infection Treatment Market Share by Type (2016-2027)
Figure 53. Latin America Hospital Acquired Infection Treatment Market Share by Application (2016-2027)
Figure 54. Latin America Hospital Acquired Infection Treatment Market Share by Country (2016-2027)
Figure 55. Mexico Hospital Acquired Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Brazil Hospital Acquired Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Middle East & Africa Hospital Acquired Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Middle East & Africa Hospital Acquired Infection Treatment Market Share by Type (2016-2027)
Figure 59. Middle East & Africa Hospital Acquired Infection Treatment Market Share by Application (2016-2027)
Figure 60. Middle East & Africa Hospital Acquired Infection Treatment Market Share by Country (2016-2027)
Figure 61. Turkey Hospital Acquired Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Saudi Arabia Hospital Acquired Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. UAE Hospital Acquired Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 64. Abbott Revenue Growth Rate in Hospital Acquired Infection Treatment Business (2016-2021)
Figure 65. Pfizer Revenue Growth Rate in Hospital Acquired Infection Treatment Business (2016-2021)
Figure 66. Bayer Revenue Growth Rate in Hospital Acquired Infection Treatment Business (2016-2021)
Figure 67. Cepheid Revenue Growth Rate in Hospital Acquired Infection Treatment Business (2016-2021)
Figure 68. AstraZeneca Revenue Growth Rate in Hospital Acquired Infection Treatment Business (2016-2021)
Figure 69. Roche Revenue Growth Rate in Hospital Acquired Infection Treatment Business (2016-2021)
Figure 70. Johnson & Johnson Revenue Growth Rate in Hospital Acquired Infection Treatment Business (2016-2021)
Figure 71. Merck Revenue Growth Rate in Hospital Acquired Infection Treatment Business (2016-2021)
Figure 72. Cipla Revenue Growth Rate in Hospital Acquired Infection Treatment Business (2016-2021)
Figure 73. GlaxoSmithKline Revenue Growth Rate in Hospital Acquired Infection Treatment Business (2016-2021)
Figure 74. Aridis Pharmaceuticals Revenue Growth Rate in Hospital Acquired Infection Treatment Business (2016-2021)
Figure 75. Astellas Pharma Revenue Growth Rate in Hospital Acquired Infection Treatment Business (2016-2021)
Figure 76. Daiichi Sankyo Revenue Growth Rate in Hospital Acquired Infection Treatment Business (2016-2021)
Figure 77. Bristol-Myers Squibb Revenue Growth Rate in Hospital Acquired Infection Treatment Business (2016-2021)
Figure 78. Eli Lilly Revenue Growth Rate in Hospital Acquired Infection Treatment Business (2016-2021)
Figure 79. Bottom-up and Top-down Approaches for This Report
Figure 80. Data Triangulation
Figure 81. Key Executives Interviewed


【掲載企業】

Abbott、Pfizer、Bayer、Cepheid、AstraZeneca、Roche、Johnson & Johnson、Merck、Cipla、GlaxoSmithKline、Aridis Pharmaceuticals、Astellas Pharma、Daiichi Sankyo、Bristol-Myers Squibb、Eli Lilly

★調査レポート[世界の院内感染症治療市場規模・現状・予測2021-2027] (コード:QY21APR2904)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の院内感染症治療市場規模・現状・予測2021-2027]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆